
1. General Information
CellCept 500 mg is a prescription medicine containing mycophenolate mofetil (MMF). It belongs to the class of medicines known as immunosuppressants. Its principal approved use is prevention of rejection in recipients of kidney, heart, or liver transplants, in combination with other immunosuppressive therapy.
Because it suppresses the immune system, patients taking CellCept require regular medical follow-up and laboratory monitoring.
2. Product Information
- Brand: CellCept
- Strength: 500 mg
- Active ingredient: Mycophenolate mofetil
- Dosage form: Film-coated tablet
- Route: Oral
- Drug class: Immunosuppressant / antimetabolite
- Primary indication: Prevention of organ rejection following kidney, heart, or liver transplantation
- Prescription status: Prescription medicine
The FDA prescribing information lists CellCept tablets in a 500 mg strength.
3. Uses of CellCept 500 mg
CellCept is primarily used:
- To help prevent rejection of a kidney transplant
- To help prevent rejection of a heart transplant
- To help prevent rejection of a liver transplant
- In combination with other medicines that suppress the immune system
The medicine reduces the immune response responsible for attacking the transplanted organ.
4. Benefits of This Medicine
When appropriately prescribed and monitored, CellCept can:
- Help reduce the risk of transplanted-organ rejection.
- Suppress an excessive immune response against the transplanted organ.
- Form part of combination immunosuppressive therapy following transplantation.
- Help maintain the function of a transplanted kidney, heart, or liver by reducing immune-mediated rejection.
The benefits depend on correct dosing, adherence, monitoring, and combination with the other medicines prescribed by the transplant specialist.
5. Side Effects of CellCept 500 mg
CellCept can cause side effects because it suppresses the immune system. Potential adverse effects include:
- Diarrhea
- Nausea and vomiting
- Abdominal or gastrointestinal problems
- Headache
- Tremor
- Swelling of the hands, feet, ankles, or lower legs
- Back, muscle, or joint pain
- Increased susceptibility to infections
- Reduced white blood cell counts
- Increased risk of certain malignancies, including lymphoma and skin cancer
Serious infections and blood abnormalities can occur and require medical attention.
6. Common Side Effects
Commonly reported adverse reactions associated with CellCept include:
- Diarrhea
- Leukopenia (low white blood cell count)
- Infections
- Vomiting
- Nausea
- Headache
- Abdominal discomfort
- Tremor
- Swelling
- Insomnia
The FDA prescribing information identifies diarrhea, leukopenia, infection, and vomiting among the most common adverse reactions in clinical trials.
7. How to Use CellCept 500 mg
Take CellCept exactly as prescribed by your transplant specialist or other healthcare professional.
General administration guidance includes:
- Take the medicine at approximately the same times each day.
- CellCept tablets are generally taken on an empty stomach, unless your doctor gives different instructions.
- Swallow the tablet whole.
- Do not crush, split, or chew the tablet.
- Do not stop treatment suddenly without speaking with your doctor because continued immunosuppression is important for preventing transplant rejection.
- If you miss a dose, follow your doctor's or pharmacist's instructions rather than taking an extra dose.
The appropriate dose varies according to the type of transplant, age, other medicines, blood counts, kidney/liver function, and clinical circumstances.
8. How CellCept Works
CellCept contains mycophenolate mofetil, which is converted in the body to mycophenolic acid (MPA).
MPA inhibits an enzyme involved in the production of purines needed by certain immune cells. This limits the growth and multiplication of T and B lymphocytes, reducing the immune response that can attack a transplanted organ.
In simple terms, CellCept lowers the immune system's attack on the transplanted organ, helping reduce the likelihood of rejection.
9. Safety Advice for This Medicine
CellCept requires particularly careful medical supervision.
Pregnancy: Mycophenolate is associated with a significant risk of miscarriage and congenital birth defects. People who can become pregnant require appropriate pregnancy prevention and testing as directed by their healthcare professional.
Infections: Because CellCept suppresses immunity, it can increase the risk of serious bacterial, viral, fungal, and other infections. Seek medical attention for symptoms such as fever, chills, persistent cough, or unusual weakness.
Blood tests: Regular laboratory monitoring is important because CellCept can cause blood-cell abnormalities, including neutropenia.
Cancer risk: Long-term immunosuppression is associated with an increased risk of lymphoma and certain skin cancers. Protect skin from excessive sunlight and avoid unnecessary tanning exposure.
Vaccinations: Do not receive vaccinations, particularly live vaccines, without first consulting your healthcare professional.
Drug interactions: Tell your doctor about all prescription medicines, OTC medicines, vitamins, and supplements. Some antacids and other medicines can affect mycophenolate exposure.
10. FAQs
Q1. What is CellCept 500 mg used for?
CellCept 500 mg is primarily used with other immunosuppressants to prevent rejection following kidney, heart, or liver transplantation.
Q2. What is the active ingredient in CellCept?
The active ingredient is mycophenolate mofetil 500 mg.
Q3. Can I stop CellCept when I feel better?
No. Do not stop it without medical advice because stopping immunosuppressive therapy can increase the risk of transplant rejection.
Q4. Can CellCept cause infections?
Yes. Because it suppresses the immune system, it can increase susceptibility to serious infections.
Q5. Can CellCept be used during pregnancy?
Mycophenolate carries a major risk of miscarriage and congenital abnormalities. Anyone who is pregnant, planning pregnancy, or capable of becoming pregnant should discuss this medicine carefully with their specialist.
Q6. Does CellCept require regular blood tests?
Yes. Doctors commonly monitor blood counts and other laboratory parameters during treatment.
Q7. Can CellCept be substituted with another mycophenolate product?
Not automatically. Different mycophenolate formulations can have different absorption characteristics and are not necessarily interchangeable without medical guidance.
11. Substitute for CellCept 500 mg
Possible alternatives containing mycophenolate mofetil include products marketed under different brand or generic names. Another formulation, mycophenolic acid delayed-release tablets (for example, Myfortic), is not automatically interchangeable with CellCept because the formulations are absorbed differently.
A transplant specialist or pharmacist should select any substitute based on the patient's transplant type, treatment regimen, formulation, dose, and monitoring requirements.
12. Keywords
CellCept 500 mg Tablets, CellCept 500 mg, CellCept tablets exporter, CellCept 500 mg exporter India, mycophenolate mofetil 500 mg, mycophenolate mofetil tablets, mycophenolate mofetil exporter, mycophenolate 500 mg tablets, immunosuppressant medicine exporter, transplant medicine exporter India, organ transplant medicines, kidney transplant medicine, heart transplant medicine, liver transplant medicine, anti rejection medicine, transplant rejection prevention medicine, prescription immunosuppressant, CellCept supplier India, CellCept pharmaceutical exporter, CellCept medicine supplier, CellCept 500 mg wholesale supplier, CellCept 500 mg export from India, pharmaceutical exporter Nagpur India, medicine exporter Nagpur, pharma exporter India to USA, pharma exporter India to UK, pharma exporter India to Australia, pharma exporter India to Canada, pharma exporter India to Singapore, pharma exporter India to South Korea, pharma exporter India to UAE, Phoenix Exim pharmaceutical exporter.
Keywords







